These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22986844)

  • 21. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks.
    Bakalis S; Stoilov B; Akolekar R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):707-14. PubMed ID: 25585604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of the Gaussian first-trimester combined screening for pre-eclampsia to predict small-for-gestational-age neonates.
    Mendoza M; Serrano B; Bonacina E; Capote S; Garcia-Manau P; Regincós L; Murcia MT; Barberan L; Míguez M; Carreras E
    Int J Gynaecol Obstet; 2022 Feb; 156(2):322-330. PubMed ID: 33724448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm.
    Mosimann B; Pfiffner C; Amylidi-Mohr S; Risch L; Surbek D; Raio L
    Swiss Med Wkly; 2017; 147():w14498. PubMed ID: 28871576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
    Fadigas C; Peeva G; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):191-7. PubMed ID: 25825848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler.
    Crovetto F; Crispi F; Scazzocchio E; Mercade I; Meler E; Figueras F; Gratacos E
    Ultrasound Obstet Gynecol; 2014 Jan; 43(1):34-40. PubMed ID: 23754253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-Trimester Uterine Artery Doppler for the Prediction of SGA at Birth: The Great Obstetrical Syndromes Study.
    Drouin O; Boutin A; Paquette K; Gasse C; Guerby P; Demers S; Bujold E
    J Obstet Gynaecol Can; 2018 Dec; 40(12):1592-1599. PubMed ID: 30314872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.
    Poon LC; Stratieva V; Piras S; Piri S; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):216-23. PubMed ID: 20108221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal hemodynamics at 11-13 weeks of gestation in pregnancies delivering small for gestational age neonates.
    Khalil A; Sodre D; Syngelaki A; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2012; 32(4):231-8. PubMed ID: 23019047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia.
    Kuc S; Koster MP; Franx A; Schielen PC; Visser GH
    PLoS One; 2013; 8(5):e63546. PubMed ID: 23717445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Serum Levels of HtrA3 at 15 Weeks of Gestation Are Associated with Late-Onset Preeclampsia Development and Small for Gestational Age Birth.
    Teoh SSY; Wang Y; Li Y; Leemaqz SY; Dekker GA; Roberts CT; Nie G
    Fetal Diagn Ther; 2019; 46(6):392-401. PubMed ID: 31013509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Dominguez C; Llurba E; Gratacós E
    Prenat Diagn; 2015 Feb; 35(2):183-91. PubMed ID: 25346181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new model for screening for early-onset preeclampsia.
    Serra B; Mendoza M; Scazzocchio E; Meler E; Nolla M; Sabrià E; Rodríguez I; Carreras E
    Am J Obstet Gynecol; 2020 Jun; 222(6):608.e1-608.e18. PubMed ID: 31972161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Screening for small-for-gestational age neonates at early third trimester in a high-risk population for preeclampsia".
    Mula R; Meler E; García S; Albaigés G; Serra B; Scazzocchio E; Prats P
    BMC Pregnancy Childbirth; 2020 Sep; 20(1):563. PubMed ID: 32988372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.